Home/Filings/4/0001209191-23-010243
4//SEC Filing

ADAMS ADRIAN 4

Accession 0001209191-23-010243

CIK 0001445499other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 6:19 PM ET

Size

5.6 KB

Accession

0001209191-23-010243

Insider Transaction Report

Form 4
Period: 2023-02-14
ADAMS ADRIAN
DirectorCOB, CEO and President
Transactions
  • Award

    Stock Option (right to buy)

    2023-02-14+200,000200,000 total
    Exercise: $2.29Exp: 2033-02-13Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 2.0833% of the total shares on March 14, 2023 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on February 14, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.

Issuer

IMPEL PHARMACEUTICALS INC

CIK 0001445499

Entity typeother

Related Parties

1
  • filerCIK 0001248144

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:19 PM ET
Size
5.6 KB